Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: A prospective randomized control trial

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 2, 2011, Pages 282-286

  Mohsen, Tarek A ^a   Zeid, Amany A Abou ^b   Meshref, Mohamed ^b   Tawfeek, Nehad ^b   Redmond, Karen ^c   Ananiadou, Olga G ^d   Haj Yahia, Saleem ^e,f  

^a CAIRO UNIVERSITY   (Egypt)

^b Cairo University   (Egypt)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d G PAPANICOLAOU HOSPITAL   (Greece)

^e GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Iodine; Malignant pleural effusion; Pleurodesis; Talc

Indexed keywords

OPIATE; POVIDONE IODINE; TALC;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DYSPNEA; FEVER; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; PLEURA BIOPSY; PLEURA EFFUSION; PLEURISY; PLEURODESIS; POVIDONE IODINE PLEURODESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; RECURRENT MALIGNANT PLEURAL EFFUSION; SURVIVAL RATE; SURVIVAL TIME; THORACOSCOPIC TALC POUDRAGE; THORAX DRAINAGE; THORAX PAIN; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; ANESTHESIA, GENERAL; BREAST NEOPLASMS; DYSPNEA; FEMALE; HUMANS; INSUFFLATION; MIDDLE AGED; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; POVIDONE-IODINE; PROSPECTIVE STUDIES; RECURRENCE; TALC; THORACIC SURGERY, VIDEO-ASSISTED; TREATMENT OUTCOME;

EID: 79960221741     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.09.005     Document Type: Article

References (22)

1. Antony V.B., Loddenkemper R., Astoul P., Boutin C., Goldstraw P., Hott J., Panadero F.R., Sahn S.A. Management of malignant pleural effusions. Eur Respir J 2001, 18:402-419.
2. Alfelstaedt J.P., Muller A.G. Breast cancer complicated by pleural effusion. J Surg Oncol 1995, 58:173-175.
3. Schulze M., Boehle A.S., Kurdow R., Dohrmann P., Burns D.H. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001, 71:1809-1812.
4. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., Flemming T., Eiermann W., Wolter J., Pegram M., Baselga J., Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that over expresses HER2. N Engl J Med 2001, 15:783-792.
5. Miller K.D., Wang M., Gralow J. A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100). Breast Cancer Res Treat 2005, 94(Suppl. 1):S6. [Abstract 3].
6. Grossi F., Penucci M.C., Tixi L., Cafferata M.A., Ardizzoni A. Management of malignant pleural effusions. Drugs 1998, 55:47-58.
7. Petrou M., Kaplan D., Goldstraw P. Management of recurrent pleural effusions. Cancer 1995, 75:801-805.
8. Ruckdeschel J.C. Management of malignant pleural effusions. Semin Oncol 1995, 22:58-63.
9. LoCicero J. Thoracoscopic management of malignant pleural effusion. Ann Thorac Surg 1993, 56:641-643.
10. Olivares-Torres C.A., Laniado-Laborin R., Chavez-Garcia C. Lodopovidone pleurodesis for recurrent pleural effusions. Chest 2002, 122:581-583.
11. Marom E., Patz E., Erasmus J., Mc Adams P., Goodman P., Herndon H. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999, 210:277-281.
12. Kelly-Garcia J., Roman-Berumen J.F., Ibarra-Perez C. Preliminary report: iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch Med Res 1997, 28:583-585.
13. Sanchez-Armengol A., Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Chest 1993, 104:1482-1485.
14. Rodriguez-Panadero F., Lopez-Mejias L. Low glucose and pH levels in malignant effusions; diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 1989, 139:663-667.
15. Good J.T., Taryle D.A., Sahn S.A. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985, 131:737-741.
16. Rodriguez-Panadero F., Lopez-Majias L. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest 1989, 95:320-324.
17. Walker-Renard P.B., Vaughan L.M., Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994, 120:56-64.
18. Kennedy L., Sahn S.A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994, 106:1215-1222.
19. Ferrer J., Montes J.F., Villarino M.A., Light R., Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002, 122:1018-1027.
20. Nick A., Maskell N.A., Lee Y.C.G., Gleeson F.V., Hedley E.L., Pengelly G., Davies R.J. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004, 170:377-382.
21. Wagenfeld L., Zeitz O., Richard G. Visual loss after povidone-iodine pleurodesis. N Engl J Med 2007, 357(12):1264-1265.
22. Shaw P., Agarwal R. Pleurodesis for malignant effusions. Cochrane Database Syst Rev 2004, (1):CD002916.